20 articles
A new global report finds longevity clinics are scaling fast but lack the standardized frameworks needed to validate their outcomes.
Industry leaders at Milan 2026 say longevity medicine must move beyond hype and deliver measurable, accountable preventive care.
Clearing zombie cells then restoring stem cell activity produced far greater lifespan gains than either approach alone.
An $80M renewal of the Long Life Family Study uncovers genes, proteins, and fitness traits that predict exceptional longevity.
Elysium Health moves beyond supplements into integrated longevity medicine, bundling prescriptions, peptides, and clinical monitoring for 10,000 members.
Health biohacker Ben Greenfield undergoes cutting-edge longevity treatments including young plasma exchange and stem cell therapy.
Dr. Stanfield exposes the $3 billion IV therapy industry's lack of evidence and hidden dangers for longevity seekers.
WashU Medicine's Long Life Family Study renewal uses long-read sequencing to decode why some families consistently escape age-related disease.
Major NIH funding supports research into exceptional longevity families and healthy aging interventions through two landmark grants.
From a massive family study of centenarians to a paradigm shift in how aging is measured, longevity science is evolving fast.
Discover the critical biomarkers that reveal your true aging trajectory and help optimize healthspan beyond standard medical checkups.
China's first standardized longevity medicine curriculum trains doctors in aging biology, cardiometabolic prevention, and AI-assisted care.
Lifespan.io reviews top rejuvenation research advances including voice-based aging biomarkers and a rapamycin-exercise clinical trial.
Six-month exercise and nutrition program reduced frailty scores and reversed epigenetic aging markers in 80-year-olds.
New genetic and proteomic findings from centenarian studies uncover biological markers that distinguish the longest-lived humans from the rest of us.
Major NIH grants target centenarian genetics and longevity consortia, signaling a new era of federally funded lifespan research.
An $80M family study, 37 proteins in centenarian blood, and a call to rethink aging as a systems failure — here's what's new.
From an $80M genetics study to a single-injection heart therapy, new research is redefining what drives exceptional human lifespan.
A landmark grant renews the Long Life Family Study, while centenarian blood protein data and new geroscience calls reshape longevity research.
Recent podcasts cover sunlight's metabolic benefits and vitamin D's impact on biological aging clocks from Nature studies.
